Avidity Biosciences Corporate Presentation November 2020

Avidity Biosciences presents its corporate overview and development strategy for targeted RNA therapies using its proprietary AOC platform. The presentation details the company's preclinical and clinical development programs aimed at treating serious genetic diseases, with a focus on advancing a new class of therapeutics.